NewDays Secures $7M To Expand Treatment for Cognitive Impairment, Dementia
NewDays, an AI company delivering cognitive health treatment, has raised $7 million in seed funding from General Catalyst and Madrona,...
NewDays, an AI company delivering cognitive health treatment, has raised $7 million in seed funding from General Catalyst and Madrona,...
OverviewMild cognitive impairment is the in-between stage between typical thinking skills and dementia. The condition causes memory loss and trouble...
Socioeconomic factors such as education, occupation, and wealth appear to influence the likelihood of developing cognitive impairment or dementia in...
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 27 November 2024, approved the medicine flortaucipir (Tauvid), a radiopharmaceutical...
What is mild cognitive impairment?Mild cognitive impairment (MCI) happens when you experience a slight — but noticeable — decline in...
There's been a flurry of attention around a new study in Frontiers in Neurology validating that the Brain Care Score,...